A Dietary Study for People With Multiple Myeloma

Part of paid clinical trials in Basking Ridge, New Jersey.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT07226609
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • nutrition counseling and coaching — OTHER
    In addition to individual counseling, patients will be able to join optional group sessions every 2 weeks as well as text message check-ins for survey completion reminders. Patients will receive 12 frozen, fixed pre-made lunch and dinner shipped to their home weekly from Modify Health for 12 weeks.
  • dietary guidelines, research dietitian visit — OTHER
    Participants will have phone calls with a member of the study team every 4 weeks as well as text message check-ins for survey completion reminders. At the end of standard induction chemotherapy, participants will have a phone call or video call with a dietitian
  • Questionnaires — BEHAVIORAL
    Block FFQ survey, EORTC QLQ C30 survey, EORTC MY20 survey, Pre intervention survey, Post intervention survey
  • Frozen pre-prepared meals — OTHER
    Patients will receive 12 frozen, fixed pre-made lunch and dinner shipped to their home weekly from Modify Health for 12 weeks.

Study Details

The purpose of the study is to find out whether a dietary intervention can affect treatment response and/or quality of life for people with newly diagnosed multiple myeloma receiving standard induction chemotherapy with daratumumab (or isatuximab), lenalidomide, bortezomib, and dexamethasone (DRVd). The researchers will measure quality of life by having participants complete questionnaires. The study will investigate the effects of diet on quality of life, treatment response, and other disease, microbiome, and immune markers.

Key Dates

Start date
Nov 4, 2025
Status verified
May 2026
Primary completion
Nov 30, 2028
Completion
Nov 30, 2028

Study Design

Enrollment
220 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Usual care (UC)
    Usual care (UC) While receiving standard induction chemotherapy as part of routine care, participants will have phone calls with a member of the study team every 4 weeks. At the end of standard induction chemotherapy, participants will have a phone call or video call with a dietitian.
  • Experimental: Intervention arm
    While receiving standard induction chemotherapy as part of routine care,participants will have a phone call or video call with a dietitian every 2 weeks for 12 weeks and will receive high-fiber plant-based meals for 12 weeks.

Primary Outcome Measure

Minimal residual disease negative complete response (MRD-CR) rate [ Time Frame: 1 year ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)Basking RidgeNew Jersey07920
Urvi A Shah, MD, MS
646-608-3713
Memorial Sloan Kettering Monmouth (Limited Protocol Activities)MiddletownNew Jersey07748
Urvi A Shah, MD, MS
646-608-3713
Memorial Sloan Kettering Bergen (Limited Protocol Activities)MontvaleNew Jersey07645
Urvi A Shah, MD, MS
646-608-3713
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)CommackNew York11725
Urvi A Shah, MD, MS
646-608-3713
Memorial Sloan Kettering Westchester (Limited Protocol Activities)HarrisonNew York10604
Urvi A Shah, MD, MS
646-608-3713
Memorial Sloan Kettering Cancer Center (All Protocol Activities)New YorkNew York10065
Urvi A Shah, MD, MS
646-608-3713
Carlyn Rose Tan, MD
646-608-3778
Memorial Sloan Kettering Nassau (Limited Protocol Activities)UniondaleNew York11553
Urvi A Shah, MD, MS
646-608-3713

Find similar trials in Basking Ridge, NJ

By condition

Related Studies